Axatilimab in Combination With Retifanlimab and Paclitaxel for the Treatment of Patients With Advanced or Metastatic Solid Tumors
Abroad (travel likely)RecruitingPHASE1, PHASE2
Conditions
Advanced Malignant Solid Neoplasm · Metastatic Malignant Solid Neoplasm · Recurrent Malignant Solid Neoplasm · Refractory Malignant Solid Neoplasm
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
OHSU Knight Cancer Institute, Portland, Oregon, United States
Contact: Principal Investigator (Shivaani Kummar)
Study leads
Shivaani Kummar
Principal Investigator
OHSU Knight Cancer Institute